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Viroj Wiwanitkit1,2,3,4* and Kamon Chaiyasit5Keyword: Antioxidant, Anticancer, CancerCancer is an important non infectious disease that can be
seen around the world and this medical disorder become
important public health threaten. The treatment of cancer
is still not fully effective and the research for improvement
of cancer therapy is still required. In the present day,
many new approaches for cancer treatment can be seen
and the use of antioxidant in cancerous patients is an
interesting topic to be discussed. In a recent editorial, the
interesting question on “By what mechanism, do you ex-
pect antioxidants to kill cancer cells?” was raised [1].
Indeed, there is still no conclusive evidence for antioxi-
dant use in cancer treatment although it might be useful
in cancer prevention [2]. Therefore, the use of antioxidant
in therapeutic process of cancer is a topic to be further
studied. Indeed, if it is believed that the “scavenging free
radical” is the main mechanism of antioxidant, the consid-
eration should be on the pharmacodynamics of both anti-
oxidant and standard antineoplastic drug. In case that
induction of free radical is the main pharmacological
process of antineoplastic drug (such as in quinine-based
compound [3]), the use of antioxidant can be useless and
should be avoided. However, in case that no drug inter-
action can be expected, the use of antioxidant can be
allowed. Focusing on the specific advantage of antioxidant
in cancer therapy, the antioxidant might be useful in the
cancerous patients with cachexia who usually got the pro-
blems of redox dysequilibrium [4]. In this scenario, the
antioxidant can help prevent Fenton reaction or reverse
Warburg effect that can lead to chemotherapy resistance
[5]. Hence, use of antioxidant supplementation in cancer-
ous cachexic patient can be useful.Competing interest
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